“Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis”
This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.
Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.
Multi-Country Prospective ObserVAtionaL, Cohort Study of Patients With Moderate to Severe Chronic PlaqUE Psoriasis (VALUE)